These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2663415)

  • 1. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
    Langley MS; Sorkin EM
    Drugs; 1989 May; 37(5):669-99. PubMed ID: 2663415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.
    Wadworth AN; McTavish D
    Drugs Aging; 1992; 2(4):262-86. PubMed ID: 1504442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation].
    Gaab MR; Rode CP; Schakel EH; Haubitz I; Bockhorn J; Brawanski A
    Klin Wochenschr; 1985 Jan; 63(1):8-15. PubMed ID: 3974174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure.
    Gaab MR; Haubitz I; Brawanski A; Korn A; Czech T
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():93-9. PubMed ID: 4010872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
    Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
    World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.
    Seker F; Hesser J; Brockmann MA; Neumaier-Probst E; Groden C; Schubert R; Brockmann C
    Clin Neuroradiol; 2017 Jun; 27(2):199-203. PubMed ID: 26350588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
    Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
    J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute stroke with calcium antagonists.
    Hülser PJ; Kornhuber AW; Kornhuber HH
    Eur Neurol; 1990; 30 Suppl 2():35-8; discussion 39-41. PubMed ID: 2180717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
    Welty TE
    Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
    Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
    J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.